CStone Pharmaceuticals (HKSE:02616) Days Sales Outstanding : 157.71 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Days Sales Outstanding?

CStone Pharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2024 was HK$141.2 Mil. CStone Pharmaceuticals's Revenue for the six months ended in Dec. 2024 was HK$163.4 Mil. Hence, CStone Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2024 was 157.71.

The historical rank and industry rank for CStone Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

HKSE:02616' s Days Sales Outstanding Range Over the Past 10 Years
Min: 78.13 Med: 107.81 Max: 176.12
Current: 131.13

During the past 9 years, CStone Pharmaceuticals's highest Days Sales Outstanding was 176.12. The lowest was 78.13. And the median was 107.81.

HKSE:02616's Days Sales Outstanding is ranked worse than
79.53% of 845 companies
in the Biotechnology industry
Industry Median: 69.43 vs HKSE:02616: 131.13

CStone Pharmaceuticals's Days Sales Outstanding increased from Dec. 2023 (155.51) to Dec. 2024 (157.71).

CStone Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for CStone Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Days Sales Outstanding Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

176.12

78.13

98.83

116.79

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial											103.60	54.97	155.51	127.20	157.71

Competitive Comparison of CStone Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, CStone Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CStone Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

CStone Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CStone Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (188.609	+	89.609)	/	2 )	/	434.761	*	365
=	139.109					/	434.761	*	365
=	116.79

CStone Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (192.802	+	89.609)	/	2 )	/	163.397	*	365 / 2
=	141.2055					/	163.397	*	365 / 2
=	157.71

CStone Pharmaceuticals (HKSE:02616) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

CStone Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

Executives

Pfizer Inc.	2201 Interest of corporation controlled by you
Yang Jianxin	2101 Beneficial owner
Boyu Capital Fund Ii, L.p.	2201 Interest of corporation controlled by you
Boyu Capital General Partner Ii, L.p.	2201 Interest of corporation controlled by you
Boyu Capital General Partner Ii, Ltd.	2201 Interest of corporation controlled by you
Boyu Capital Holdings Ltd.	2201 Interest of corporation controlled by you
Graceful Beauty Limited	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Jian Kang Chuang Ye Tou Zi Guan Li Zhong Xin You Xian He Huo	2501 Other
Su Zhou Gong Ye Yuan Qu Yuan He Yuan Dian Chuang Ye Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Guan Wei Hui	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Jing Ji Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Yuan He Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo	2101 Beneficial owner

CStone Pharmaceuticals Headlines

No Headlines